Image-01 (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 01)
Zileuton
Product Images NDC 68180-169
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 68180-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-02 (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 02)
Image (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 03)
This text describes a medication called Zileuton manufactured by Lupin Pharmaceuticals Inc. It comes in film-coated tablets that are 600mg each, and is meant to be dispensed with accompanying patient information. The usual dosage instructions are found in the package insert, but patients are cautioned not to chew, cut, or crush the tablets. Storage instructions advise keeping the medication at room temperature in a tight, light-resistant container. The medication should not be accepted if the seal over the bottle opening is broken or missing.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
